Gagnon Securities LLC Trims Stock Holdings in Aspen Aerogels, Inc. $ASPN

Gagnon Securities LLC decreased its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 7.6% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 1,754,833 shares of the construction company’s stock after selling 144,275 shares during the period. Aspen Aerogels accounts for 2.5% of Gagnon Securities LLC’s investment portfolio, making the stock its 16th largest position. Gagnon Securities LLC’s holdings in Aspen Aerogels were worth $12,214,000 as of its most recent filing with the SEC.

A number of other hedge funds have also added to or reduced their stakes in ASPN. Federated Hermes Inc. bought a new stake in shares of Aspen Aerogels during the second quarter valued at about $10,459,000. Geode Capital Management LLC grew its stake in Aspen Aerogels by 4.4% during the second quarter. Geode Capital Management LLC now owns 1,582,742 shares of the construction company’s stock valued at $9,371,000 after acquiring an additional 66,967 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after buying an additional 602,586 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Aspen Aerogels by 105.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,246,506 shares of the construction company’s stock worth $7,379,000 after acquiring an additional 639,753 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in shares of Aspen Aerogels by 1,045.5% in the 2nd quarter. Invesco Ltd. now owns 831,991 shares of the construction company’s stock valued at $4,925,000 after acquiring an additional 759,360 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 56,845 shares of the stock in a transaction that occurred on Thursday, November 13th. The stock was sold at an average price of $3.23, for a total transaction of $183,609.35. Following the completion of the sale, the chief executive officer owned 494,011 shares of the company’s stock, valued at approximately $1,595,655.53. This represents a 10.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 4.30% of the company’s stock.

Analyst Ratings Changes

ASPN has been the subject of several recent analyst reports. Zacks Research raised Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, December 29th. Canaccord Genuity Group decreased their price target on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Finally, Barclays lowered their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research report on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $12.67.

Aspen Aerogels Stock Up 5.4%

Shares of NYSE:ASPN opened at $3.62 on Friday. The stock has a market capitalization of $298.78 million, a P/E ratio of -0.97 and a beta of 2.94. The stock’s 50-day moving average price is $3.26 and its 200-day moving average price is $5.64. The company has a current ratio of 3.94, a quick ratio of 3.33 and a debt-to-equity ratio of 0.28. Aspen Aerogels, Inc. has a 12-month low of $2.80 and a 12-month high of $12.71.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The company had revenue of $73.02 million for the quarter, compared to analysts’ expectations of $73.42 million. During the same quarter in the prior year, the company earned ($0.17) earnings per share. The company’s revenue was down 37.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.